Aziyo Biologics (ELUT)
NASDAQ:ELUT
US Market
Holding ELUT?
Track your performance easily

Aziyo Biologics (ELUT) Balance Sheet

54 Followers

Aziyo Biologics Balance Sheet

Aziyo Biologics's total assets for Q2 2024 were $41.90M, an increase of 18.50% from the previous quarter. ELUT total liabilities were $106.24M for the fiscal quarter, a 24.03% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 43.43M$ 68.84M$ 67.17M$ 82.81M$ 44.77M
Total Liabilities
$ 82.03M$ 73.87M$ 53.65M$ 61.98M$ 99.88M
Total Equity Gross Minority
$ -25.84M$ -5.04M$ 13.52M$ 20.83M$ -55.11M
Total Capitalization
$ 2.11M$ 44.44M$ 23.93M$ 38.64M$ -35.50M
Preferred Stock Equity
-----
Capital Lease Obligations
-----
Currency in USD

Aziyo Biologics Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis